Myocardial iron loading in patients with thalassemia major in Turkey and the potential role of splenectomy in myocardial siderosis

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 5, 2011, Pages 374-378

  Aydinok, Yesim ^a   Bayraktaroglu, Selen ^a   Yildiz, Dilek ^a   Alper, Hudaver ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

iron overload; myocardial siderosis; Thalassemia

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; IRON;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART HEMOSIDEROSIS; HEART MUSCLE; HUMAN; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MUSCLE LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; SPLEEN FUNCTION; SPLENECTOMY; THALASSEMIA MAJOR; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; FERRITINS; HUMANS; IRON; MIDDLE AGED; MYOCARDIUM; PREVALENCE; SIDEROSIS; SPLENECTOMY; TURKEY; YOUNG ADULT;

EID: 79959846505     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31820c34ef     Document Type: Article

References (17)

1. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179. (Pubitemid 33139463)
2. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961-1968.
3. Wood JC, Origa R, Agus A, et al. Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica. 2008;93:917-920. (Pubitemid 351821730)
4. Graziano JH, Piomelli S, Hilgartner M, et al. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. Pediatr. 1981;99:695-699. (Pubitemid 12229134)
5. Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111:583-587.
6. Theurl I, Ludwiczek S, Eller P, et al. Pathways for the regulation of body iron homeostasis in response to experimental iron overload. J Hepatol. 2005;43:711-719. (Pubitemid 41253240)
7. Fischer R, Tiemann CD, Engelhardt R, et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol. 1999;60:289-299. (Pubitemid 29160089)
8. Taner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on Deferoxamine chelation. J Cardiovasc Magn Reson. 2006;8:543-547.
9. Olivieri NF, Brittenham GM. Iron chelating therapy and the treatment of Thalassemia. Blood. 1997;89:739-761. (Pubitemid 27121266)
10. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Eng J Med. 1994;31: 567-573. (Pubitemid 24265698)
11. Aessopos A, Fragodimitri C, Karabatsos F. Cardiac magnetic resonance imaging R2 assessments and analysis of historical parameters in patients with transfusion dependent thalassemia. Haematologica. 2007;92:131-132. (Pubitemid 46232670)
12. Brewer CJ, Coates TD, Wood JC. Spleen R2 and R2* in iron overloaded patients with sickle cell disease and thalassemia major. J Cardiovasc Magn Reson. 2009;29:357-364.
13. Piga A, Longo F, Duca L, et al. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol. 2009;84:29-33.
14. Taher A, Musallam KM, El Rassi F, et al. Levels of nontransferrin bound iron as an index of iron overload in patients with thalassemia intermedia. Br J Hematol. 2009;146: 569-572.
15. Fiorelli G, Fargion S, Piperno A, et al. Iron metabolism in thalassemia intermedia. Haematologica. 1990;75(supple 5): 89-95. (Pubitemid 20359675)
16. Cappellini MD, Tavazzi D, Duca L, et al. Non-transferrin bound iron, iron related oxidative stress and lipid peroxidation in beta thalassemia intermedia. Transfusion Science. 2000;23:245-246.
17. Tavazzi D, Duca L, Graziadei G, et al. Membrane bound iron contributes to oxidative damage of beta thalassemia intermedia erythrocytes. Br J Hematol. 2001;112:48-50. (Pubitemid 32151148)